Inscription Capital’s Labcorp LH Stock Holding History

Inscription Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,945	Closed	-$519K	–	831
2026 Q1	$519K	Sell	1,945 -33	-2%	-$8.94K	0.05%	352
2025 Q4	$496K	Buy	+1,978	New	+$525K	0.05%	363

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Inscription Capital's LH Position: Q2 2026 in Review

Inscription Capital sold out of Labcorp (LH) in Q2 2026, closing a stake of 1,945 shares — an estimated $519K sold.

Inscription Capital first reported a position in LH in Q4 2025 and held it in 2 quarters. The position peaked at $519K in Q1 2026. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Inscription Capital reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
Inscription Capital sold 1,945 Labcorp shares in Q2 2026, an estimated $519K.
Inscription Capital first reported a position in Labcorp in Q4 2025 and held it in 2 quarters.
Inscription Capital's Labcorp position peaked at $519K in Q1 2026.
1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.